PHARMACOKINETICS AND BIOAVAILABILITY OF TRANEXAMIC ACID

被引:227
作者
PILBRANT, A [1 ]
SCHANNONG, M [1 ]
VESSMAN, J [1 ]
机构
[1] KABI AB,DEPT RES,S-11287 STOCKHOLM,SWEDEN
关键词
D O I
10.1007/BF00554669
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:65 / 72
页数:8
相关论文
共 14 条
[1]   ROLE OF UROKINASE AND TISSUE ACTIVATOR IN SUSTAINING BLEEDING AND MANAGEMENT THEREOF WITH EACA AND AMCA [J].
ANDERSSON, L ;
NILSOON, IM ;
COLLEEN, S ;
GRANSTRAND, B ;
MELANDER, B .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1968, 146 (A2) :642-+
[2]   STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].
BOXENBAU.HG ;
RIEGELMA.S ;
ELASHOFF, RM .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148
[3]  
CORMACK F, 1973, LANCET, V1, P1207
[4]   PHARMACOKINETICS OF TRANEXAMIC ACID AFTER INTRAVENOUS ADMINISTRATION TO NORMAL VOLUNTEERS [J].
ERIKSSON, O ;
KJELLMAN, H ;
PILBRANT, A ;
SCHANNONG, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (05) :375-380
[5]  
HEDLUND P O, 1969, Scandinavian Journal of Urology and Nephrology, V3, P177, DOI 10.3109/00365596909135401
[6]  
Metzler C.M., 1974, USERS MANUAL NONLIN
[7]   ERRORS INVOLVED IN INSTANTANEOUS INTRAVASCULAR INPUT ASSUMPTIONS [J].
NIAZI, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (05) :750-752
[8]   TREATMENT OF MENORRHAGIA WITH AN ANTIFIBRINOLYTIC AGENT TRANEXAMIC ACID (AMCA) - A DOUBLE BLIND INVESTIGATION [J].
NILSSON, L ;
RYBO, G .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1967, 46 (04) :572-&
[9]  
TOVI D, 1973, ACTA NEUROL SCAND, V49, P163
[10]   FIBRINOLYSIS AND SUBARACHNOID HEMORRHAGE - INHIBITORY EFFECT OF TRANEXAMIC ACID - CLINICAL STUDY [J].
TOVI, D ;
THULIN, C ;
NILSSON, IM .
ACTA NEUROLOGICA SCANDINAVICA, 1972, 48 (04) :393-&